nodes	percent_of_prediction	percent_of_DWPC	metapath
Acetaminophen—CYP2A6—Ifosfamide—testicular cancer	0.0889	0.129	CbGbCtD
Acetaminophen—PTGS1—Ifosfamide—testicular cancer	0.076	0.11	CbGbCtD
Acetaminophen—UGT1A1—Etoposide—testicular cancer	0.0715	0.104	CbGbCtD
Acetaminophen—CYP2C8—Ifosfamide—testicular cancer	0.0438	0.0636	CbGbCtD
Acetaminophen—PTGS2—Cisplatin—testicular cancer	0.0438	0.0635	CbGbCtD
Acetaminophen—PTGS2—Etoposide—testicular cancer	0.043	0.0624	CbGbCtD
Acetaminophen—PTGS1—Etoposide—testicular cancer	0.0363	0.0527	CbGbCtD
Acetaminophen—CYP2C9—Ifosfamide—testicular cancer	0.0306	0.0444	CbGbCtD
Acetaminophen—CYP2E1—Etoposide—testicular cancer	0.028	0.0407	CbGbCtD
Acetaminophen—ABCB1—Dactinomycin—testicular cancer	0.0251	0.0365	CbGbCtD
Acetaminophen—SLC22A6—Methotrexate—testicular cancer	0.021	0.0305	CbGbCtD
Acetaminophen—CYP2C8—Etoposide—testicular cancer	0.021	0.0304	CbGbCtD
Acetaminophen—CYP3A4—Ifosfamide—testicular cancer	0.0178	0.0258	CbGbCtD
Acetaminophen—CYP1A2—Etoposide—testicular cancer	0.0162	0.0235	CbGbCtD
Acetaminophen—ABCB1—Vinblastine—testicular cancer	0.0157	0.0228	CbGbCtD
Acetaminophen—CYP2C9—Cisplatin—testicular cancer	0.0149	0.0216	CbGbCtD
Acetaminophen—CYP2D6—Vinblastine—testicular cancer	0.0148	0.0215	CbGbCtD
Acetaminophen—ABCB1—Cisplatin—testicular cancer	0.0144	0.021	CbGbCtD
Acetaminophen—ABCB1—Etoposide—testicular cancer	0.0142	0.0206	CbGbCtD
Acetaminophen—ABCB1—Doxorubicin—testicular cancer	0.00967	0.014	CbGbCtD
Acetaminophen—CYP3A4—Vinblastine—testicular cancer	0.00943	0.0137	CbGbCtD
Acetaminophen—ABCB1—Methotrexate—testicular cancer	0.00937	0.0136	CbGbCtD
Acetaminophen—CYP2D6—Doxorubicin—testicular cancer	0.00911	0.0132	CbGbCtD
Acetaminophen—CYP3A4—Etoposide—testicular cancer	0.0085	0.0123	CbGbCtD
Acetaminophen—CYP3A4—Doxorubicin—testicular cancer	0.0058	0.00841	CbGbCtD
Acetaminophen—SULT1A1—seminal vesicle—testicular cancer	0.00501	0.0748	CbGeAlD
Acetaminophen—SULT2A1—gonad—testicular cancer	0.00455	0.0681	CbGeAlD
Acetaminophen—SULT1E1—gonad—testicular cancer	0.0042	0.0628	CbGeAlD
Acetaminophen—SULT2A1—female gonad—testicular cancer	0.0037	0.0553	CbGeAlD
Acetaminophen—UGT1A6—testis—testicular cancer	0.00353	0.0528	CbGeAlD
Acetaminophen—SULT1E1—female gonad—testicular cancer	0.00342	0.0511	CbGeAlD
Acetaminophen—SULT2A1—testis—testicular cancer	0.00328	0.0491	CbGeAlD
Acetaminophen—TRPV1—gonad—testicular cancer	0.00318	0.0476	CbGeAlD
Acetaminophen—SULT1E1—testis—testicular cancer	0.00303	0.0453	CbGeAlD
Acetaminophen—SULT1A1—female gonad—testicular cancer	0.00294	0.0439	CbGeAlD
Acetaminophen—CNR1—testis—testicular cancer	0.00283	0.0424	CbGeAlD
Acetaminophen—SULT1A1—testis—testicular cancer	0.00261	0.039	CbGeAlD
Acetaminophen—SULT2A1—lymph node—testicular cancer	0.00238	0.0356	CbGeAlD
Acetaminophen—TRPV1—testis—testicular cancer	0.0023	0.0343	CbGeAlD
Acetaminophen—SULT1E1—lymph node—testicular cancer	0.0022	0.0328	CbGeAlD
Acetaminophen—CYP2A6—seminal vesicle—testicular cancer	0.00211	0.0316	CbGeAlD
Acetaminophen—CNR1—lymph node—testicular cancer	0.00205	0.0307	CbGeAlD
Acetaminophen—SULT1A1—lymph node—testicular cancer	0.00189	0.0283	CbGeAlD
Acetaminophen—UGT1A6—NRF2 pathway—SLC2A6—testicular cancer	0.00111	0.0505	CbGpPWpGaD
Acetaminophen—SULT1E1—Phase II conjugation—HPGDS—testicular cancer	0.00107	0.0484	CbGpPWpGaD
Acetaminophen—CYP2E1—seminal vesicle—testicular cancer	0.000999	0.0149	CbGeAlD
Acetaminophen—PTGS2—embryo—testicular cancer	0.00098	0.0146	CbGeAlD
Acetaminophen—PTGS1—seminal vesicle—testicular cancer	0.000963	0.0144	CbGeAlD
Acetaminophen—PTGS1—Synthesis of Prostaglandins (PG) and Thromboxanes (TX)—HPGDS—testicular cancer	0.000953	0.0432	CbGpPWpGaD
Acetaminophen—SULT1A1—Phase II conjugation—HPGDS—testicular cancer	0.00094	0.0426	CbGpPWpGaD
Acetaminophen—PTGS2—seminal vesicle—testicular cancer	0.00092	0.0138	CbGeAlD
Acetaminophen—SULT2A1—Phase II conjugation—HPGDS—testicular cancer	0.000809	0.0367	CbGpPWpGaD
Acetaminophen—NAT2—Phase II conjugation—HPGDS—testicular cancer	0.000772	0.035	CbGpPWpGaD
Acetaminophen—PTGS2—Synthesis of Prostaglandins (PG) and Thromboxanes (TX)—HPGDS—testicular cancer	0.000756	0.0343	CbGpPWpGaD
Acetaminophen—UGT2B15—Phase II conjugation—HPGDS—testicular cancer	0.000726	0.0329	CbGpPWpGaD
Acetaminophen—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A6—testicular cancer	0.000689	0.0313	CbGpPWpGaD
Acetaminophen—CYP1A1—female gonad—testicular cancer	0.000643	0.00962	CbGeAlD
Acetaminophen—SULT1E1—Biological oxidations—HPGDS—testicular cancer	0.000624	0.0283	CbGpPWpGaD
Acetaminophen—CYP2C8—testis—testicular cancer	0.000618	0.00924	CbGeAlD
Acetaminophen—ABCB1—embryo—testicular cancer	0.000606	0.00906	CbGeAlD
Acetaminophen—UGT1A6—Phase II conjugation—HPGDS—testicular cancer	0.000606	0.0275	CbGpPWpGaD
Acetaminophen—CNR1—Class A/1 (Rhodopsin-like receptors)—INSL3—testicular cancer	0.000589	0.0267	CbGpPWpGaD
Acetaminophen—ABCB1—seminal vesicle—testicular cancer	0.000569	0.00851	CbGeAlD
Acetaminophen—PTGS1—female gonad—testicular cancer	0.000565	0.00845	CbGeAlD
Acetaminophen—SULT1A1—Biological oxidations—HPGDS—testicular cancer	0.00055	0.0249	CbGpPWpGaD
Acetaminophen—PTGS2—female gonad—testicular cancer	0.00054	0.00808	CbGeAlD
Acetaminophen—TRPV1—Transmembrane transport of small molecules—SLC2A6—testicular cancer	0.000534	0.0242	CbGpPWpGaD
Acetaminophen—CYP2E1—testis—testicular cancer	0.00052	0.00778	CbGeAlD
Acetaminophen—PTGS1—testis—testicular cancer	0.000501	0.00749	CbGeAlD
Acetaminophen—UGT1A1—NRF2 pathway—SLC2A6—testicular cancer	0.000493	0.0224	CbGpPWpGaD
Acetaminophen—UGT1A9—NRF2 pathway—SLC2A6—testicular cancer	0.000493	0.0224	CbGpPWpGaD
Acetaminophen—SULT2A1—Biological oxidations—HPGDS—testicular cancer	0.000473	0.0215	CbGpPWpGaD
Acetaminophen—CYP2D6—female gonad—testicular cancer	0.000465	0.00695	CbGeAlD
Acetaminophen—NAT2—Biological oxidations—HPGDS—testicular cancer	0.000451	0.0205	CbGpPWpGaD
Acetaminophen—CNR1—GPCR ligand binding—INSL3—testicular cancer	0.000449	0.0204	CbGpPWpGaD
Acetaminophen—UGT2B15—Biological oxidations—HPGDS—testicular cancer	0.000424	0.0193	CbGpPWpGaD
Acetaminophen—CYP1A1—lymph node—testicular cancer	0.000414	0.00618	CbGeAlD
Acetaminophen—CYP2D6—testis—testicular cancer	0.000412	0.00616	CbGeAlD
Acetaminophen—ABCB1—gonad—testicular cancer	0.000411	0.00615	CbGeAlD
Acetaminophen—CYP2A6—NRF2 pathway—SLC2A6—testicular cancer	0.00038	0.0173	CbGpPWpGaD
Acetaminophen—PTGS1—lymph node—testicular cancer	0.000363	0.00543	CbGeAlD
Acetaminophen—UGT1A6—Biological oxidations—HPGDS—testicular cancer	0.000354	0.0161	CbGpPWpGaD
Acetaminophen—PTGS2—lymph node—testicular cancer	0.000347	0.00519	CbGeAlD
Acetaminophen—PTGS1—Arachidonic acid metabolism—HPGDS—testicular cancer	0.000344	0.0156	CbGpPWpGaD
Acetaminophen—ABCB1—female gonad—testicular cancer	0.000334	0.005	CbGeAlD
Acetaminophen—SLC22A6—SLC-mediated transmembrane transport—SLC2A6—testicular cancer	0.000313	0.0142	CbGpPWpGaD
Acetaminophen—ABCB1—testis—testicular cancer	0.000296	0.00443	CbGeAlD
Acetaminophen—PTGS2—Aryl Hydrocarbon Receptor—HPGDS—testicular cancer	0.000292	0.0132	CbGpPWpGaD
Acetaminophen—PTGS2—Arachidonic acid metabolism—HPGDS—testicular cancer	0.000273	0.0124	CbGpPWpGaD
Acetaminophen—UGT1A1—Phase II conjugation—HPGDS—testicular cancer	0.000269	0.0122	CbGpPWpGaD
Acetaminophen—UGT1A9—Phase II conjugation—HPGDS—testicular cancer	0.000269	0.0122	CbGpPWpGaD
Acetaminophen—CYP1A1—Aryl Hydrocarbon Receptor—HPGDS—testicular cancer	0.000259	0.0118	CbGpPWpGaD
Acetaminophen—CNR1—GPCR downstream signaling—INSL3—testicular cancer	0.000254	0.0115	CbGpPWpGaD
Acetaminophen—CYP1A1—Arachidonic acid metabolism—HPGDS—testicular cancer	0.000242	0.011	CbGpPWpGaD
Acetaminophen—CNR1—Signaling by GPCR—INSL3—testicular cancer	0.00023	0.0104	CbGpPWpGaD
Acetaminophen—CYP2C8—Arachidonic acid metabolism—HPGDS—testicular cancer	0.000222	0.0101	CbGpPWpGaD
Acetaminophen—ABCB1—lymph node—testicular cancer	0.000215	0.00321	CbGeAlD
Acetaminophen—Somnolence—Etoposide—testicular cancer	0.000212	0.000956	CcSEcCtD
Acetaminophen—Hepatobiliary disease—Methotrexate—testicular cancer	0.000212	0.000955	CcSEcCtD
Acetaminophen—Nausea—Bleomycin—testicular cancer	0.00021	0.000946	CcSEcCtD
Acetaminophen—Drowsiness—Epirubicin—testicular cancer	0.00021	0.000945	CcSEcCtD
Acetaminophen—Vomiting—Dactinomycin—testicular cancer	0.00021	0.000945	CcSEcCtD
Acetaminophen—Agranulocytosis—Methotrexate—testicular cancer	0.000209	0.000942	CcSEcCtD
Acetaminophen—Stevens-Johnson syndrome—Epirubicin—testicular cancer	0.000208	0.000937	CcSEcCtD
Acetaminophen—Rash—Dactinomycin—testicular cancer	0.000208	0.000937	CcSEcCtD
Acetaminophen—Decreased appetite—Etoposide—testicular cancer	0.000208	0.000935	CcSEcCtD
Acetaminophen—Diarrhoea—Ifosfamide—testicular cancer	0.000207	0.000931	CcSEcCtD
Acetaminophen—Pancytopenia—Doxorubicin—testicular cancer	0.000207	0.000931	CcSEcCtD
Acetaminophen—Gastrointestinal disorder—Etoposide—testicular cancer	0.000206	0.000928	CcSEcCtD
Acetaminophen—Body temperature increased—Cisplatin—testicular cancer	0.000206	0.000928	CcSEcCtD
Acetaminophen—Fatigue—Etoposide—testicular cancer	0.000206	0.000927	CcSEcCtD
Acetaminophen—Constipation—Etoposide—testicular cancer	0.000204	0.000919	CcSEcCtD
Acetaminophen—Dysuria—Doxorubicin—testicular cancer	0.000204	0.000917	CcSEcCtD
Acetaminophen—Neutropenia—Doxorubicin—testicular cancer	0.000204	0.000917	CcSEcCtD
Acetaminophen—Haemoglobin—Methotrexate—testicular cancer	0.000202	0.000911	CcSEcCtD
Acetaminophen—Hepatitis—Methotrexate—testicular cancer	0.000201	0.000907	CcSEcCtD
Acetaminophen—Haemorrhage—Methotrexate—testicular cancer	0.000201	0.000907	CcSEcCtD
Acetaminophen—Sweating—Epirubicin—testicular cancer	0.000201	0.000906	CcSEcCtD
Acetaminophen—Dizziness—Ifosfamide—testicular cancer	0.0002	0.0009	CcSEcCtD
Acetaminophen—Urinary tract disorder—Methotrexate—testicular cancer	0.000199	0.000895	CcSEcCtD
Acetaminophen—Photosensitivity reaction—Doxorubicin—testicular cancer	0.000199	0.000895	CcSEcCtD
Acetaminophen—Hepatobiliary disease—Epirubicin—testicular cancer	0.000199	0.000894	CcSEcCtD
Acetaminophen—Urethral disorder—Methotrexate—testicular cancer	0.000197	0.000889	CcSEcCtD
Acetaminophen—Feeling abnormal—Etoposide—testicular cancer	0.000197	0.000886	CcSEcCtD
Acetaminophen—Hyperglycaemia—Doxorubicin—testicular cancer	0.000197	0.000885	CcSEcCtD
Acetaminophen—Nausea—Dactinomycin—testicular cancer	0.000196	0.000882	CcSEcCtD
Acetaminophen—Agranulocytosis—Epirubicin—testicular cancer	0.000196	0.000882	CcSEcCtD
Acetaminophen—Gastrointestinal pain—Etoposide—testicular cancer	0.000195	0.000879	CcSEcCtD
Acetaminophen—Drowsiness—Doxorubicin—testicular cancer	0.000194	0.000874	CcSEcCtD
Acetaminophen—Stevens-Johnson syndrome—Doxorubicin—testicular cancer	0.000193	0.000867	CcSEcCtD
Acetaminophen—Vomiting—Ifosfamide—testicular cancer	0.000192	0.000866	CcSEcCtD
Acetaminophen—Hypersensitivity—Cisplatin—testicular cancer	0.000192	0.000865	CcSEcCtD
Acetaminophen—Rash—Ifosfamide—testicular cancer	0.000191	0.000858	CcSEcCtD
Acetaminophen—Dermatitis—Ifosfamide—testicular cancer	0.000191	0.000858	CcSEcCtD
Acetaminophen—Erythema multiforme—Methotrexate—testicular cancer	0.00019	0.000857	CcSEcCtD
Acetaminophen—Urticaria—Etoposide—testicular cancer	0.00019	0.000854	CcSEcCtD
Acetaminophen—Haemoglobin—Epirubicin—testicular cancer	0.000189	0.000853	CcSEcCtD
Acetaminophen—PTGS2—C-MYB transcription factor network—MAD1L1—testicular cancer	0.000189	0.00858	CbGpPWpGaD
Acetaminophen—Body temperature increased—Etoposide—testicular cancer	0.000189	0.00085	CcSEcCtD
Acetaminophen—Abdominal pain—Etoposide—testicular cancer	0.000189	0.00085	CcSEcCtD
Acetaminophen—Haemorrhage—Epirubicin—testicular cancer	0.000188	0.000848	CcSEcCtD
Acetaminophen—Hepatitis—Epirubicin—testicular cancer	0.000188	0.000848	CcSEcCtD
Acetaminophen—Eye disorder—Methotrexate—testicular cancer	0.000188	0.000847	CcSEcCtD
Acetaminophen—Asthenia—Cisplatin—testicular cancer	0.000187	0.000842	CcSEcCtD
Acetaminophen—Cardiac disorder—Methotrexate—testicular cancer	0.000187	0.000841	CcSEcCtD
Acetaminophen—Sweating—Doxorubicin—testicular cancer	0.000186	0.000838	CcSEcCtD
Acetaminophen—Urinary tract disorder—Epirubicin—testicular cancer	0.000186	0.000838	CcSEcCtD
Acetaminophen—Oedema peripheral—Epirubicin—testicular cancer	0.000186	0.000836	CcSEcCtD
Acetaminophen—Connective tissue disorder—Epirubicin—testicular cancer	0.000185	0.000834	CcSEcCtD
Acetaminophen—Urethral disorder—Epirubicin—testicular cancer	0.000185	0.000832	CcSEcCtD
Acetaminophen—Hepatobiliary disease—Doxorubicin—testicular cancer	0.000184	0.000827	CcSEcCtD
Acetaminophen—Angiopathy—Methotrexate—testicular cancer	0.000183	0.000822	CcSEcCtD
Acetaminophen—Immune system disorder—Methotrexate—testicular cancer	0.000182	0.000819	CcSEcCtD
Acetaminophen—SULT2A1—Metabolism of lipids and lipoproteins—HPGDS—testicular cancer	0.000182	0.00825	CbGpPWpGaD
Acetaminophen—Mediastinal disorder—Methotrexate—testicular cancer	0.000182	0.000817	CcSEcCtD
Acetaminophen—Agranulocytosis—Doxorubicin—testicular cancer	0.000181	0.000816	CcSEcCtD
Acetaminophen—CYP2C9—Arachidonic acid metabolism—HPGDS—testicular cancer	0.000181	0.00821	CbGpPWpGaD
Acetaminophen—Chills—Methotrexate—testicular cancer	0.000181	0.000813	CcSEcCtD
Acetaminophen—Nausea—Ifosfamide—testicular cancer	0.00018	0.000809	CcSEcCtD
Acetaminophen—Diarrhoea—Cisplatin—testicular cancer	0.000178	0.000803	CcSEcCtD
Acetaminophen—Erythema multiforme—Epirubicin—testicular cancer	0.000178	0.000802	CcSEcCtD
Acetaminophen—Mental disorder—Methotrexate—testicular cancer	0.000176	0.000794	CcSEcCtD
Acetaminophen—Eye disorder—Epirubicin—testicular cancer	0.000176	0.000793	CcSEcCtD
Acetaminophen—Hypersensitivity—Etoposide—testicular cancer	0.000176	0.000792	CcSEcCtD
Acetaminophen—Erythema—Methotrexate—testicular cancer	0.000175	0.000789	CcSEcCtD
Acetaminophen—Malnutrition—Methotrexate—testicular cancer	0.000175	0.000789	CcSEcCtD
Acetaminophen—Haemoglobin—Doxorubicin—testicular cancer	0.000175	0.000789	CcSEcCtD
Acetaminophen—Cardiac disorder—Epirubicin—testicular cancer	0.000175	0.000787	CcSEcCtD
Acetaminophen—Flushing—Epirubicin—testicular cancer	0.000175	0.000787	CcSEcCtD
Acetaminophen—Haemorrhage—Doxorubicin—testicular cancer	0.000174	0.000785	CcSEcCtD
Acetaminophen—Hepatitis—Doxorubicin—testicular cancer	0.000174	0.000785	CcSEcCtD
Acetaminophen—Urinary tract disorder—Doxorubicin—testicular cancer	0.000172	0.000775	CcSEcCtD
Acetaminophen—Oedema peripheral—Doxorubicin—testicular cancer	0.000172	0.000773	CcSEcCtD
Acetaminophen—Asthenia—Etoposide—testicular cancer	0.000171	0.000771	CcSEcCtD
Acetaminophen—Connective tissue disorder—Doxorubicin—testicular cancer	0.000171	0.000771	CcSEcCtD
Acetaminophen—Angiopathy—Epirubicin—testicular cancer	0.000171	0.00077	CcSEcCtD
Acetaminophen—Urethral disorder—Doxorubicin—testicular cancer	0.000171	0.000769	CcSEcCtD
Acetaminophen—Immune system disorder—Epirubicin—testicular cancer	0.00017	0.000766	CcSEcCtD
Acetaminophen—Mediastinal disorder—Epirubicin—testicular cancer	0.00017	0.000765	CcSEcCtD
Acetaminophen—Chills—Epirubicin—testicular cancer	0.000169	0.000761	CcSEcCtD
Acetaminophen—Pruritus—Etoposide—testicular cancer	0.000169	0.000761	CcSEcCtD
Acetaminophen—Vomiting—Cisplatin—testicular cancer	0.000166	0.000746	CcSEcCtD
Acetaminophen—CYP1A2—Aryl Hydrocarbon Receptor—HPGDS—testicular cancer	0.000165	0.0075	CbGpPWpGaD
Acetaminophen—Vision blurred—Methotrexate—testicular cancer	0.000165	0.000744	CcSEcCtD
Acetaminophen—Mental disorder—Epirubicin—testicular cancer	0.000165	0.000743	CcSEcCtD
Acetaminophen—Erythema multiforme—Doxorubicin—testicular cancer	0.000165	0.000742	CcSEcCtD
Acetaminophen—Rash—Cisplatin—testicular cancer	0.000164	0.00074	CcSEcCtD
Acetaminophen—Dermatitis—Cisplatin—testicular cancer	0.000164	0.000739	CcSEcCtD
Acetaminophen—Malnutrition—Epirubicin—testicular cancer	0.000164	0.000739	CcSEcCtD
Acetaminophen—Erythema—Epirubicin—testicular cancer	0.000164	0.000739	CcSEcCtD
Acetaminophen—Diarrhoea—Etoposide—testicular cancer	0.000163	0.000736	CcSEcCtD
Acetaminophen—Eye disorder—Doxorubicin—testicular cancer	0.000163	0.000734	CcSEcCtD
Acetaminophen—Ill-defined disorder—Methotrexate—testicular cancer	0.000163	0.000732	CcSEcCtD
Acetaminophen—Anaemia—Methotrexate—testicular cancer	0.000162	0.000729	CcSEcCtD
Acetaminophen—Flushing—Doxorubicin—testicular cancer	0.000162	0.000729	CcSEcCtD
Acetaminophen—Cardiac disorder—Doxorubicin—testicular cancer	0.000162	0.000729	CcSEcCtD
Acetaminophen—Tension—Epirubicin—testicular cancer	0.000161	0.000725	CcSEcCtD
Acetaminophen—Nervousness—Epirubicin—testicular cancer	0.000159	0.000717	CcSEcCtD
Acetaminophen—SLC22A6—Transmembrane transport of small molecules—SLC2A6—testicular cancer	0.000159	0.00722	CbGpPWpGaD
Acetaminophen—Angiopathy—Doxorubicin—testicular cancer	0.000158	0.000712	CcSEcCtD
Acetaminophen—Malaise—Methotrexate—testicular cancer	0.000158	0.000712	CcSEcCtD
Acetaminophen—Dizziness—Etoposide—testicular cancer	0.000158	0.000711	CcSEcCtD
Acetaminophen—Muscle spasms—Epirubicin—testicular cancer	0.000158	0.00071	CcSEcCtD
Acetaminophen—Immune system disorder—Doxorubicin—testicular cancer	0.000158	0.000709	CcSEcCtD
Acetaminophen—Mediastinal disorder—Doxorubicin—testicular cancer	0.000157	0.000707	CcSEcCtD
Acetaminophen—UGT1A1—Biological oxidations—HPGDS—testicular cancer	0.000157	0.00713	CbGpPWpGaD
Acetaminophen—UGT1A9—Biological oxidations—HPGDS—testicular cancer	0.000157	0.00713	CbGpPWpGaD
Acetaminophen—Leukopenia—Methotrexate—testicular cancer	0.000157	0.000706	CcSEcCtD
Acetaminophen—Chills—Doxorubicin—testicular cancer	0.000156	0.000704	CcSEcCtD
Acetaminophen—Nausea—Cisplatin—testicular cancer	0.000155	0.000697	CcSEcCtD
Acetaminophen—Vision blurred—Epirubicin—testicular cancer	0.000155	0.000696	CcSEcCtD
Acetaminophen—CYP1A2—Arachidonic acid metabolism—HPGDS—testicular cancer	0.000155	0.00701	CbGpPWpGaD
Acetaminophen—Cough—Methotrexate—testicular cancer	0.000153	0.000689	CcSEcCtD
Acetaminophen—Mental disorder—Doxorubicin—testicular cancer	0.000153	0.000688	CcSEcCtD
Acetaminophen—Ill-defined disorder—Epirubicin—testicular cancer	0.000152	0.000685	CcSEcCtD
Acetaminophen—Convulsion—Methotrexate—testicular cancer	0.000152	0.000684	CcSEcCtD
Acetaminophen—Vomiting—Etoposide—testicular cancer	0.000152	0.000684	CcSEcCtD
Acetaminophen—Erythema—Doxorubicin—testicular cancer	0.000152	0.000683	CcSEcCtD
Acetaminophen—Malnutrition—Doxorubicin—testicular cancer	0.000152	0.000683	CcSEcCtD
Acetaminophen—Anaemia—Epirubicin—testicular cancer	0.000152	0.000683	CcSEcCtD
Acetaminophen—Agitation—Epirubicin—testicular cancer	0.000151	0.000679	CcSEcCtD
Acetaminophen—Rash—Etoposide—testicular cancer	0.000151	0.000678	CcSEcCtD
Acetaminophen—Dermatitis—Etoposide—testicular cancer	0.00015	0.000677	CcSEcCtD
Acetaminophen—Headache—Etoposide—testicular cancer	0.00015	0.000674	CcSEcCtD
Acetaminophen—Chest pain—Methotrexate—testicular cancer	0.000149	0.000672	CcSEcCtD
Acetaminophen—Tension—Doxorubicin—testicular cancer	0.000149	0.000671	CcSEcCtD
Acetaminophen—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—testicular cancer	0.000148	0.000667	CcSEcCtD
Acetaminophen—Malaise—Epirubicin—testicular cancer	0.000148	0.000666	CcSEcCtD
Acetaminophen—Discomfort—Methotrexate—testicular cancer	0.000147	0.000664	CcSEcCtD
Acetaminophen—Nervousness—Doxorubicin—testicular cancer	0.000147	0.000664	CcSEcCtD
Acetaminophen—Leukopenia—Epirubicin—testicular cancer	0.000147	0.000661	CcSEcCtD
Acetaminophen—Muscle spasms—Doxorubicin—testicular cancer	0.000146	0.000657	CcSEcCtD
Acetaminophen—Palpitations—Epirubicin—testicular cancer	0.000145	0.000653	CcSEcCtD
Acetaminophen—Confusional state—Methotrexate—testicular cancer	0.000144	0.000649	CcSEcCtD
Acetaminophen—Cough—Epirubicin—testicular cancer	0.000143	0.000644	CcSEcCtD
Acetaminophen—Anaphylactic shock—Methotrexate—testicular cancer	0.000143	0.000644	CcSEcCtD
Acetaminophen—Vision blurred—Doxorubicin—testicular cancer	0.000143	0.000644	CcSEcCtD
Acetaminophen—Convulsion—Epirubicin—testicular cancer	0.000142	0.00064	CcSEcCtD
Acetaminophen—Nausea—Etoposide—testicular cancer	0.000142	0.000639	CcSEcCtD
Acetaminophen—Hypertension—Epirubicin—testicular cancer	0.000142	0.000638	CcSEcCtD
Acetaminophen—Ill-defined disorder—Doxorubicin—testicular cancer	0.000141	0.000634	CcSEcCtD
Acetaminophen—Nervous system disorder—Methotrexate—testicular cancer	0.00014	0.000632	CcSEcCtD
Acetaminophen—Anaemia—Doxorubicin—testicular cancer	0.00014	0.000632	CcSEcCtD
Acetaminophen—Thrombocytopenia—Methotrexate—testicular cancer	0.00014	0.000631	CcSEcCtD
Acetaminophen—Chest pain—Epirubicin—testicular cancer	0.00014	0.000629	CcSEcCtD
Acetaminophen—Agitation—Doxorubicin—testicular cancer	0.00014	0.000628	CcSEcCtD
Acetaminophen—Anxiety—Epirubicin—testicular cancer	0.000139	0.000627	CcSEcCtD
Acetaminophen—Skin disorder—Methotrexate—testicular cancer	0.000139	0.000626	CcSEcCtD
Acetaminophen—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—testicular cancer	0.000139	0.000624	CcSEcCtD
Acetaminophen—Hyperhidrosis—Methotrexate—testicular cancer	0.000138	0.000623	CcSEcCtD
Acetaminophen—Discomfort—Epirubicin—testicular cancer	0.000138	0.000621	CcSEcCtD
Acetaminophen—Malaise—Doxorubicin—testicular cancer	0.000137	0.000616	CcSEcCtD
Acetaminophen—Dry mouth—Epirubicin—testicular cancer	0.000137	0.000615	CcSEcCtD
Acetaminophen—Anorexia—Methotrexate—testicular cancer	0.000136	0.000614	CcSEcCtD
Acetaminophen—CNR1—Signaling Pathways—INSL3—testicular cancer	0.000136	0.00617	CbGpPWpGaD
Acetaminophen—Leukopenia—Doxorubicin—testicular cancer	0.000136	0.000612	CcSEcCtD
Acetaminophen—Confusional state—Epirubicin—testicular cancer	0.000135	0.000608	CcSEcCtD
Acetaminophen—Palpitations—Doxorubicin—testicular cancer	0.000134	0.000604	CcSEcCtD
Acetaminophen—Anaphylactic shock—Epirubicin—testicular cancer	0.000134	0.000603	CcSEcCtD
Acetaminophen—Oedema—Epirubicin—testicular cancer	0.000134	0.000603	CcSEcCtD
Acetaminophen—Hypotension—Methotrexate—testicular cancer	0.000134	0.000602	CcSEcCtD
Acetaminophen—Cough—Doxorubicin—testicular cancer	0.000132	0.000596	CcSEcCtD
Acetaminophen—PTGS2—C-MYB transcription factor network—H2AFZ—testicular cancer	0.000132	0.00598	CbGpPWpGaD
Acetaminophen—Shock—Epirubicin—testicular cancer	0.000132	0.000593	CcSEcCtD
Acetaminophen—Convulsion—Doxorubicin—testicular cancer	0.000132	0.000592	CcSEcCtD
Acetaminophen—Nervous system disorder—Epirubicin—testicular cancer	0.000131	0.000591	CcSEcCtD
Acetaminophen—Thrombocytopenia—Epirubicin—testicular cancer	0.000131	0.00059	CcSEcCtD
Acetaminophen—Hypertension—Doxorubicin—testicular cancer	0.000131	0.00059	CcSEcCtD
Acetaminophen—Tachycardia—Epirubicin—testicular cancer	0.000131	0.000588	CcSEcCtD
Acetaminophen—Skin disorder—Epirubicin—testicular cancer	0.00013	0.000585	CcSEcCtD
Acetaminophen—Hyperhidrosis—Epirubicin—testicular cancer	0.000129	0.000583	CcSEcCtD
Acetaminophen—Insomnia—Methotrexate—testicular cancer	0.000129	0.000583	CcSEcCtD
Acetaminophen—Chest pain—Doxorubicin—testicular cancer	0.000129	0.000582	CcSEcCtD
Acetaminophen—Anxiety—Doxorubicin—testicular cancer	0.000129	0.00058	CcSEcCtD
Acetaminophen—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—testicular cancer	0.000128	0.000578	CcSEcCtD
Acetaminophen—PTGS1—Biological oxidations—HPGDS—testicular cancer	0.000128	0.00581	CbGpPWpGaD
Acetaminophen—Discomfort—Doxorubicin—testicular cancer	0.000128	0.000575	CcSEcCtD
Acetaminophen—Anorexia—Epirubicin—testicular cancer	0.000128	0.000575	CcSEcCtD
Acetaminophen—Dyspnoea—Methotrexate—testicular cancer	0.000128	0.000574	CcSEcCtD
Acetaminophen—Somnolence—Methotrexate—testicular cancer	0.000127	0.000573	CcSEcCtD
Acetaminophen—Dry mouth—Doxorubicin—testicular cancer	0.000126	0.000569	CcSEcCtD
Acetaminophen—Dyspepsia—Methotrexate—testicular cancer	0.000126	0.000567	CcSEcCtD
Acetaminophen—Hypotension—Epirubicin—testicular cancer	0.000125	0.000563	CcSEcCtD
Acetaminophen—Confusional state—Doxorubicin—testicular cancer	0.000125	0.000562	CcSEcCtD
Acetaminophen—Decreased appetite—Methotrexate—testicular cancer	0.000124	0.00056	CcSEcCtD
Acetaminophen—Oedema—Doxorubicin—testicular cancer	0.000124	0.000558	CcSEcCtD
Acetaminophen—Anaphylactic shock—Doxorubicin—testicular cancer	0.000124	0.000558	CcSEcCtD
Acetaminophen—Gastrointestinal disorder—Methotrexate—testicular cancer	0.000124	0.000556	CcSEcCtD
Acetaminophen—Fatigue—Methotrexate—testicular cancer	0.000123	0.000555	CcSEcCtD
Acetaminophen—Shock—Doxorubicin—testicular cancer	0.000122	0.000549	CcSEcCtD
Acetaminophen—Nervous system disorder—Doxorubicin—testicular cancer	0.000122	0.000547	CcSEcCtD
Acetaminophen—Thrombocytopenia—Doxorubicin—testicular cancer	0.000121	0.000546	CcSEcCtD
Acetaminophen—PTGS2—C-MYB transcription factor network—KITLG—testicular cancer	0.000121	0.0055	CbGpPWpGaD
Acetaminophen—Insomnia—Epirubicin—testicular cancer	0.000121	0.000545	CcSEcCtD
Acetaminophen—CYP2A6—Biological oxidations—HPGDS—testicular cancer	0.000121	0.0055	CbGpPWpGaD
Acetaminophen—Tachycardia—Doxorubicin—testicular cancer	0.000121	0.000544	CcSEcCtD
Acetaminophen—Skin disorder—Doxorubicin—testicular cancer	0.00012	0.000542	CcSEcCtD
Acetaminophen—Hyperhidrosis—Doxorubicin—testicular cancer	0.00012	0.000539	CcSEcCtD
Acetaminophen—Dyspnoea—Epirubicin—testicular cancer	0.000119	0.000537	CcSEcCtD
Acetaminophen—Somnolence—Epirubicin—testicular cancer	0.000119	0.000536	CcSEcCtD
Acetaminophen—Anorexia—Doxorubicin—testicular cancer	0.000118	0.000532	CcSEcCtD
Acetaminophen—Feeling abnormal—Methotrexate—testicular cancer	0.000118	0.000531	CcSEcCtD
Acetaminophen—Dyspepsia—Epirubicin—testicular cancer	0.000118	0.000531	CcSEcCtD
Acetaminophen—Gastrointestinal pain—Methotrexate—testicular cancer	0.000117	0.000527	CcSEcCtD
Acetaminophen—Decreased appetite—Epirubicin—testicular cancer	0.000116	0.000524	CcSEcCtD
Acetaminophen—Hypotension—Doxorubicin—testicular cancer	0.000116	0.000521	CcSEcCtD
Acetaminophen—Gastrointestinal disorder—Epirubicin—testicular cancer	0.000116	0.00052	CcSEcCtD
Acetaminophen—Fatigue—Epirubicin—testicular cancer	0.000115	0.00052	CcSEcCtD
Acetaminophen—Constipation—Epirubicin—testicular cancer	0.000115	0.000515	CcSEcCtD
Acetaminophen—Urticaria—Methotrexate—testicular cancer	0.000114	0.000512	CcSEcCtD
Acetaminophen—Body temperature increased—Methotrexate—testicular cancer	0.000113	0.000509	CcSEcCtD
Acetaminophen—Abdominal pain—Methotrexate—testicular cancer	0.000113	0.000509	CcSEcCtD
Acetaminophen—Insomnia—Doxorubicin—testicular cancer	0.000112	0.000504	CcSEcCtD
Acetaminophen—Dyspnoea—Doxorubicin—testicular cancer	0.00011	0.000497	CcSEcCtD
Acetaminophen—Feeling abnormal—Epirubicin—testicular cancer	0.00011	0.000497	CcSEcCtD
Acetaminophen—Somnolence—Doxorubicin—testicular cancer	0.00011	0.000496	CcSEcCtD
Acetaminophen—Gastrointestinal pain—Epirubicin—testicular cancer	0.00011	0.000493	CcSEcCtD
Acetaminophen—Dyspepsia—Doxorubicin—testicular cancer	0.000109	0.000491	CcSEcCtD
Acetaminophen—Decreased appetite—Doxorubicin—testicular cancer	0.000108	0.000485	CcSEcCtD
Acetaminophen—Gastrointestinal disorder—Doxorubicin—testicular cancer	0.000107	0.000481	CcSEcCtD
Acetaminophen—Fatigue—Doxorubicin—testicular cancer	0.000107	0.000481	CcSEcCtD
Acetaminophen—SULT1E1—Metabolism—HPGDS—testicular cancer	0.000107	0.00485	CbGpPWpGaD
Acetaminophen—Urticaria—Epirubicin—testicular cancer	0.000106	0.000479	CcSEcCtD
Acetaminophen—Constipation—Doxorubicin—testicular cancer	0.000106	0.000477	CcSEcCtD
Acetaminophen—Abdominal pain—Epirubicin—testicular cancer	0.000106	0.000476	CcSEcCtD
Acetaminophen—Body temperature increased—Epirubicin—testicular cancer	0.000106	0.000476	CcSEcCtD
Acetaminophen—Hypersensitivity—Methotrexate—testicular cancer	0.000105	0.000475	CcSEcCtD
Acetaminophen—Asthenia—Methotrexate—testicular cancer	0.000103	0.000462	CcSEcCtD
Acetaminophen—Feeling abnormal—Doxorubicin—testicular cancer	0.000102	0.00046	CcSEcCtD
Acetaminophen—Gastrointestinal pain—Doxorubicin—testicular cancer	0.000101	0.000456	CcSEcCtD
Acetaminophen—Pruritus—Methotrexate—testicular cancer	0.000101	0.000456	CcSEcCtD
Acetaminophen—Hypersensitivity—Epirubicin—testicular cancer	9.87e-05	0.000444	CcSEcCtD
Acetaminophen—Urticaria—Doxorubicin—testicular cancer	9.84e-05	0.000443	CcSEcCtD
Acetaminophen—CYP1A2—Phase II conjugation—HPGDS—testicular cancer	9.83e-05	0.00446	CbGpPWpGaD
Acetaminophen—Body temperature increased—Doxorubicin—testicular cancer	9.79e-05	0.000441	CcSEcCtD
Acetaminophen—Abdominal pain—Doxorubicin—testicular cancer	9.79e-05	0.000441	CcSEcCtD
Acetaminophen—Diarrhoea—Methotrexate—testicular cancer	9.79e-05	0.000441	CcSEcCtD
Acetaminophen—Asthenia—Epirubicin—testicular cancer	9.61e-05	0.000432	CcSEcCtD
Acetaminophen—CYP2E1—Biological oxidations—HPGDS—testicular cancer	9.57e-05	0.00434	CbGpPWpGaD
Acetaminophen—Pruritus—Epirubicin—testicular cancer	9.47e-05	0.000426	CcSEcCtD
Acetaminophen—Dizziness—Methotrexate—testicular cancer	9.46e-05	0.000426	CcSEcCtD
Acetaminophen—SULT1A1—Metabolism—HPGDS—testicular cancer	9.4e-05	0.00427	CbGpPWpGaD
Acetaminophen—PTGS2—Integrated Pancreatic Cancer Pathway—HPGDS—testicular cancer	9.35e-05	0.00424	CbGpPWpGaD
Acetaminophen—Diarrhoea—Epirubicin—testicular cancer	9.16e-05	0.000412	CcSEcCtD
Acetaminophen—Hypersensitivity—Doxorubicin—testicular cancer	9.13e-05	0.000411	CcSEcCtD
Acetaminophen—Vomiting—Methotrexate—testicular cancer	9.1e-05	0.000409	CcSEcCtD
Acetaminophen—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—KIT—testicular cancer	9.03e-05	0.0041	CbGpPWpGaD
Acetaminophen—CYP1A1—Biological oxidations—HPGDS—testicular cancer	9.02e-05	0.00409	CbGpPWpGaD
Acetaminophen—Rash—Methotrexate—testicular cancer	9.02e-05	0.000406	CcSEcCtD
Acetaminophen—Dermatitis—Methotrexate—testicular cancer	9.01e-05	0.000406	CcSEcCtD
Acetaminophen—Headache—Methotrexate—testicular cancer	8.96e-05	0.000403	CcSEcCtD
Acetaminophen—Asthenia—Doxorubicin—testicular cancer	8.89e-05	0.0004	CcSEcCtD
Acetaminophen—Dizziness—Epirubicin—testicular cancer	8.86e-05	0.000399	CcSEcCtD
Acetaminophen—Pruritus—Doxorubicin—testicular cancer	8.77e-05	0.000395	CcSEcCtD
Acetaminophen—Vomiting—Epirubicin—testicular cancer	8.51e-05	0.000383	CcSEcCtD
Acetaminophen—Nausea—Methotrexate—testicular cancer	8.5e-05	0.000383	CcSEcCtD
Acetaminophen—Diarrhoea—Doxorubicin—testicular cancer	8.48e-05	0.000382	CcSEcCtD
Acetaminophen—Rash—Epirubicin—testicular cancer	8.44e-05	0.00038	CcSEcCtD
Acetaminophen—Dermatitis—Epirubicin—testicular cancer	8.44e-05	0.00038	CcSEcCtD
Acetaminophen—Headache—Epirubicin—testicular cancer	8.39e-05	0.000378	CcSEcCtD
Acetaminophen—PTGS2—C-MYB transcription factor network—KIT—testicular cancer	8.27e-05	0.00375	CbGpPWpGaD
Acetaminophen—CYP2C8—Biological oxidations—HPGDS—testicular cancer	8.27e-05	0.00375	CbGpPWpGaD
Acetaminophen—Dizziness—Doxorubicin—testicular cancer	8.19e-05	0.000369	CcSEcCtD
Acetaminophen—SULT2A1—Metabolism—HPGDS—testicular cancer	8.09e-05	0.00367	CbGpPWpGaD
Acetaminophen—Nausea—Epirubicin—testicular cancer	7.95e-05	0.000358	CcSEcCtD
Acetaminophen—Vomiting—Doxorubicin—testicular cancer	7.88e-05	0.000355	CcSEcCtD
Acetaminophen—Rash—Doxorubicin—testicular cancer	7.81e-05	0.000352	CcSEcCtD
Acetaminophen—Dermatitis—Doxorubicin—testicular cancer	7.81e-05	0.000351	CcSEcCtD
Acetaminophen—Headache—Doxorubicin—testicular cancer	7.76e-05	0.000349	CcSEcCtD
Acetaminophen—SULT1E1—Metabolism—STK11—testicular cancer	7.76e-05	0.00352	CbGpPWpGaD
Acetaminophen—NAT2—Metabolism—HPGDS—testicular cancer	7.72e-05	0.0035	CbGpPWpGaD
Acetaminophen—Nausea—Doxorubicin—testicular cancer	7.36e-05	0.000331	CcSEcCtD
Acetaminophen—UGT2B15—Metabolism—HPGDS—testicular cancer	7.26e-05	0.00329	CbGpPWpGaD
Acetaminophen—ABCB1—Transmembrane transport of small molecules—SLC2A6—testicular cancer	7.25e-05	0.00329	CbGpPWpGaD
Acetaminophen—SULT1A1—Metabolism—STK11—testicular cancer	6.83e-05	0.0031	CbGpPWpGaD
Acetaminophen—PTGS2—Integrated Pancreatic Cancer Pathway—STK11—testicular cancer	6.79e-05	0.00308	CbGpPWpGaD
Acetaminophen—CYP2D6—Biological oxidations—HPGDS—testicular cancer	6.79e-05	0.00308	CbGpPWpGaD
Acetaminophen—CYP2C9—Biological oxidations—HPGDS—testicular cancer	6.73e-05	0.00305	CbGpPWpGaD
Acetaminophen—ABCB1—Integrated Pancreatic Cancer Pathway—HPGDS—testicular cancer	6.63e-05	0.00301	CbGpPWpGaD
Acetaminophen—UGT1A6—Metabolism—HPGDS—testicular cancer	6.06e-05	0.00275	CbGpPWpGaD
Acetaminophen—UGT1A9—Metabolism of lipids and lipoproteins—HPGDS—testicular cancer	6.03e-05	0.00274	CbGpPWpGaD
Acetaminophen—SULT2A1—Metabolism—STK11—testicular cancer	5.88e-05	0.00267	CbGpPWpGaD
Acetaminophen—CYP1A2—Biological oxidations—HPGDS—testicular cancer	5.75e-05	0.00261	CbGpPWpGaD
Acetaminophen—NAT2—Metabolism—STK11—testicular cancer	5.61e-05	0.00255	CbGpPWpGaD
Acetaminophen—UGT2B15—Metabolism—STK11—testicular cancer	5.27e-05	0.00239	CbGpPWpGaD
Acetaminophen—PTGS1—Metabolism of lipids and lipoproteins—HPGDS—testicular cancer	4.92e-05	0.00223	CbGpPWpGaD
Acetaminophen—ABCB1—Integrated Pancreatic Cancer Pathway—STK11—testicular cancer	4.82e-05	0.00218	CbGpPWpGaD
Acetaminophen—CYP3A4—Biological oxidations—HPGDS—testicular cancer	4.44e-05	0.00201	CbGpPWpGaD
Acetaminophen—UGT1A6—Metabolism—STK11—testicular cancer	4.4e-05	0.002	CbGpPWpGaD
Acetaminophen—CNR1—Signaling Pathways—H2AFZ—testicular cancer	4.35e-05	0.00198	CbGpPWpGaD
Acetaminophen—CNR1—Signaling Pathways—STK11—testicular cancer	4.33e-05	0.00196	CbGpPWpGaD
Acetaminophen—CNR1—Signaling Pathways—KITLG—testicular cancer	4.01e-05	0.00182	CbGpPWpGaD
Acetaminophen—PTGS2—Metabolism of lipids and lipoproteins—HPGDS—testicular cancer	3.9e-05	0.00177	CbGpPWpGaD
Acetaminophen—CYP1A1—Metabolism of lipids and lipoproteins—HPGDS—testicular cancer	3.46e-05	0.00157	CbGpPWpGaD
Acetaminophen—CYP2C8—Metabolism of lipids and lipoproteins—HPGDS—testicular cancer	3.18e-05	0.00144	CbGpPWpGaD
Acetaminophen—CNR1—Signaling Pathways—FGFR3—testicular cancer	2.98e-05	0.00135	CbGpPWpGaD
Acetaminophen—CNR1—Signaling Pathways—KIT—testicular cancer	2.73e-05	0.00124	CbGpPWpGaD
Acetaminophen—UGT1A1—Metabolism—HPGDS—testicular cancer	2.69e-05	0.00122	CbGpPWpGaD
Acetaminophen—UGT1A9—Metabolism—HPGDS—testicular cancer	2.69e-05	0.00122	CbGpPWpGaD
Acetaminophen—CYP2C9—Metabolism of lipids and lipoproteins—HPGDS—testicular cancer	2.59e-05	0.00117	CbGpPWpGaD
Acetaminophen—CYP1A2—Metabolism of lipids and lipoproteins—HPGDS—testicular cancer	2.21e-05	0.001	CbGpPWpGaD
Acetaminophen—PTGS1—Metabolism—HPGDS—testicular cancer	2.19e-05	0.000994	CbGpPWpGaD
Acetaminophen—CYP2A6—Metabolism—HPGDS—testicular cancer	2.07e-05	0.00094	CbGpPWpGaD
Acetaminophen—UGT1A1—Metabolism—STK11—testicular cancer	1.95e-05	0.000886	CbGpPWpGaD
Acetaminophen—UGT1A9—Metabolism—STK11—testicular cancer	1.95e-05	0.000886	CbGpPWpGaD
Acetaminophen—PTGS2—Metabolism—HPGDS—testicular cancer	1.74e-05	0.000789	CbGpPWpGaD
Acetaminophen—CYP2E1—Metabolism—HPGDS—testicular cancer	1.64e-05	0.000743	CbGpPWpGaD
Acetaminophen—PTGS1—Metabolism—STK11—testicular cancer	1.59e-05	0.000722	CbGpPWpGaD
Acetaminophen—CYP1A1—Metabolism—HPGDS—testicular cancer	1.54e-05	0.0007	CbGpPWpGaD
Acetaminophen—PTGS2—Disease—H2AFZ—testicular cancer	1.52e-05	0.000688	CbGpPWpGaD
Acetaminophen—CYP2A6—Metabolism—STK11—testicular cancer	1.5e-05	0.000683	CbGpPWpGaD
Acetaminophen—CYP2C8—Metabolism—HPGDS—testicular cancer	1.41e-05	0.000642	CbGpPWpGaD
Acetaminophen—PTGS2—Disease—KITLG—testicular cancer	1.4e-05	0.000633	CbGpPWpGaD
Acetaminophen—PTGS2—Metabolism—STK11—testicular cancer	1.26e-05	0.000573	CbGpPWpGaD
Acetaminophen—ABCB1—Metabolism—HPGDS—testicular cancer	1.23e-05	0.000559	CbGpPWpGaD
Acetaminophen—CYP2E1—Metabolism—STK11—testicular cancer	1.19e-05	0.00054	CbGpPWpGaD
Acetaminophen—CYP2D6—Metabolism—HPGDS—testicular cancer	1.16e-05	0.000527	CbGpPWpGaD
Acetaminophen—CYP2C9—Metabolism—HPGDS—testicular cancer	1.15e-05	0.000522	CbGpPWpGaD
Acetaminophen—CYP1A1—Metabolism—STK11—testicular cancer	1.12e-05	0.000509	CbGpPWpGaD
Acetaminophen—PTGS2—Disease—FGFR3—testicular cancer	1.04e-05	0.000471	CbGpPWpGaD
Acetaminophen—CYP2C8—Metabolism—STK11—testicular cancer	1.03e-05	0.000466	CbGpPWpGaD
Acetaminophen—CYP1A2—Metabolism—HPGDS—testicular cancer	9.84e-06	0.000446	CbGpPWpGaD
Acetaminophen—PTGS2—Disease—KIT—testicular cancer	9.52e-06	0.000432	CbGpPWpGaD
Acetaminophen—ABCB1—Metabolism—STK11—testicular cancer	8.95e-06	0.000406	CbGpPWpGaD
Acetaminophen—CYP2D6—Metabolism—STK11—testicular cancer	8.44e-06	0.000383	CbGpPWpGaD
Acetaminophen—CYP2C9—Metabolism—STK11—testicular cancer	8.37e-06	0.00038	CbGpPWpGaD
Acetaminophen—CYP3A4—Metabolism—HPGDS—testicular cancer	7.59e-06	0.000345	CbGpPWpGaD
Acetaminophen—CYP1A2—Metabolism—STK11—testicular cancer	7.15e-06	0.000324	CbGpPWpGaD
Acetaminophen—CYP3A4—Metabolism—STK11—testicular cancer	5.52e-06	0.00025	CbGpPWpGaD
